Top Stories

The Silent Enemy: Insulin Resistance

Published by Gbaf News

Posted on April 18, 2018

3 min read

· Last updated: January 21, 2026

Add as preferred source on Google
UK's FTSE 100 and financial markets react to Russia's embassy statement on G7 loans to Ukraine - Global Banking & Finance Review
The image illustrates the UK's FTSE 100 index performance amid the controversy over G7 loans to Ukraine backed by frozen Russian assets. This reflects the ongoing financial tension and geopolitical implications discussed in the article.
Global Banking & Finance Awards 2026 — Call for Entries

The MealPlanner, the MedTech company creating solutions in the fight against diet related diseases has begun the development of their new App, MIRA Health-My Insulin Resistance App with the support of an EU-PERMIDES grant & collaboration with the National Netherlands Insurance within the Sparklab program. Insulin Resistance (IR) is undiagnosed in 90% of the population […]

The MealPlanner, the MedTech company creating solutions in the fight against diet related diseases has begun the development of their new App, MIRA Health-My Insulin Resistance App with the support of an EU-PERMIDES grant & collaboration with the National Netherlands Insurance within the Sparklab program.

Insulin Resistance (IR) is undiagnosed in 90% of the population that suffers from this precursor to serious, life-changing, diet centered disease. IR is the precursor of such health problems as polycystic ovary syndrome (PCOS), infertility, heart disease and diabetes, all of which have reached epidemic proportions, globally.

The MealPlanner combats insulin resistance in three ways:

  • Create awareness about IR. Even medical professionals confuse IR with pre-diabetes so public education is important for everyone. The outcome of this education is to get people to diagnose and test for IR from time to time just as we do with breast and prostate cancers.
  • With the PERMIDES grant we are creating a self-diagnostic tool to make preliminary diagnoses easy and free for all.
  • Our App supports the efforts of people to manage their IR with proper nutrition. The only way to prevent the onset of more serious disease is to learn healthy and mindful nutrition.

In addition to the EU grant the project has received its first 100k seed investment.

The Mealplanner is seeking further public participation in their efforts to educate the public about diet based disease and give them the tools needed to fight for healthy solutions. To learn more about the company and see further investment possibility click here.

The MealPlanner, the MedTech company creating solutions in the fight against diet related diseases has begun the development of their new App, MIRA Health-My Insulin Resistance App with the support of an EU-PERMIDES grant & collaboration with the National Netherlands Insurance within the Sparklab program.

Insulin Resistance (IR) is undiagnosed in 90% of the population that suffers from this precursor to serious, life-changing, diet centered disease. IR is the precursor of such health problems as polycystic ovary syndrome (PCOS), infertility, heart disease and diabetes, all of which have reached epidemic proportions, globally.

The MealPlanner combats insulin resistance in three ways:

  • Create awareness about IR. Even medical professionals confuse IR with pre-diabetes so public education is important for everyone. The outcome of this education is to get people to diagnose and test for IR from time to time just as we do with breast and prostate cancers.
  • With the PERMIDES grant we are creating a self-diagnostic tool to make preliminary diagnoses easy and free for all.
  • Our App supports the efforts of people to manage their IR with proper nutrition. The only way to prevent the onset of more serious disease is to learn healthy and mindful nutrition.

In addition to the EU grant the project has received its first 100k seed investment.

The Mealplanner is seeking further public participation in their efforts to educate the public about diet based disease and give them the tools needed to fight for healthy solutions. To learn more about the company and see further investment possibility click here.

Related Articles

More from Top Stories

Explore more articles in the Top Stories category